OFIX - Lowey Dannenberg P.C. is Investigating Orthofix Medical Inc. (NASDAQ: OFIX) for Potential Breaches of Fiduciary Duty by Its Board of Directors

NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating a potential breach of fiduciary duty claim involving the board of directors of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX). This investigation is in connection with Orthofix’s firing of its Chief Executive Officer Keith Valentine, Chief Financial Officer John Bostjancic, and Chief Legal Officer Patrick Keran. As Orthofix stated, the Board of Directors determined that each executive engaged in “repeated inappropriate and offensive conduct” that violated multiple code-of-conduct requirements and is inconsistent with the Company’s values and culture.

If you are a shareholder of Orthofix, and wish to participate, learn more, or discuss the issues surrounding the investigation, attorneys at (914) 733-7256 or via email to Andrea Farah (afarah@lowey.com) or Vincent R. Cappucci Jr. (vcappucci@lowey.com).

About Lowey Dannenberg

Lowey Dannenberg is a national firm representing institutional and individual investors, who suffered financial losses resulting from corporate fraud and malfeasance in violation of federal securities and antitrust laws. The firm has significant experience in prosecuting multi-million-dollar lawsuits and has previously recovered billions of dollars on behalf of investors.

Contact

Lowey Dannenberg P.C.
44 South Broadway, Suite 1100
White Plains, NY 10601
Tel: (914) 733-7256
Email:  investigations@lowey.com

SOURCE: Lowey Dannenberg